Log In
BCIQ
Print this Print this
 

Epirubicin Micelle (K-912) (NC-6300)

  Manage Alerts
Collapse Summary General Information
Company NanoCarrier Co. Ltd.
DescriptionMicellar nanoparticle which incorporates epirubicin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$31.2M

$2.6M

$28.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/10/2011

$31.2M

$2.6M

$28.6M

Get a free BioCentury trial today